Kromann Reumert advises Coloplast in connection with the acquisition of Atos Medical
Kromann Reumert has advised Coloplast in connection with entering into an agreement to acquire Atos Medical, the global market leader in laryngectomy, for EUR 2,155 million (around DKK 16 billion) from PAI Partners, a global private equity firm headquartered in Paris.
Atos Medical represents a new long-term growth category for Coloplast operating with its own identity, brand and execution strength while benefitting from the industry leading capabilities and track record of Coloplast to drive continuous growth and value creation.
Following the expected completion of the acquisition, Coloplast gains access to a new chronic care segment to be run as a separate strategic business unit operating on shared Coloplast infrastructure.
Closing of the transaction is subject to customary regulatory approvals and is anticipated in Q2 2021/22.
Contact
